GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Change In Payables And Accrued Expense

NFL Biosciences (XPAR:ALNFL) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Change In Payables And Accrued Expense?

NFL Biosciences's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was €0.00 Mil. It means NFL Biosciences's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Jun. 2024 .

NFL Biosciences's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means NFL Biosciences's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


NFL Biosciences Change In Payables And Accrued Expense Historical Data

The historical data trend for NFL Biosciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Change In Payables And Accrued Expense Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

NFL Biosciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NFL Biosciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


NFL Biosciences Business Description

Industry
Traded in Other Exchanges
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences Headlines

No Headlines